Picture of Atrys Health SA logo

ATRY — Atrys Health SA News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Brief: Atrys Health Sees 2019 Recurring EBITDA Proforma In Estimated Range Between 6.6 Mln Euros And 7.0 Mln Euros

Oct 25 (Reuters) - Atrys Health SA  ATRY.MC :
    * SAID ON THURSDAY SEES 2019 PROFORMA REVENUE IN AN
ESTIMATED
RANGE BETWEEN 19.5 MILLION EUROS AND 20 MILLION EUROS
    * SEES 2019 RECURRING EBITDA PROFORMA IN AN ESTIMATED RANGE
BETWEEN 6.6 MILLION EUROS AND 7.0 MILLION EUROS 
    * 2019 PROFORMA INCLUDES FULL-YEAR IMPACT OF ACQUISITIONS OF
REAL
LIFE DATA, TELERADIOLOGIA DE COLOMBIA AND IMOR

    
 Source text: https://bit.ly/341OZ6J
    
 Further company coverage:  ATRY.MC  
   


 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))

Recent news on Atrys Health SA

See all news